CARDIO inCode-Score® US study publication | 04-Apr-2024 | 10:44 | RNS |
New NICE Guidance for Ovarian Cancer | 21-Mar-2024 | 10:58 | RNS |
Holding(s) in Company | 09-Feb-2024 | 10:00 | RNS |
Holding(s) in Company | 15-Jan-2024 | 07:00 | RNS |
Holding(s) in Company | 11-Jan-2024 | 14:49 | RNS |
Holding(s) in Company | 11-Jan-2024 | 14:30 | RNS |
Result of GM and Total Voting Rights | 09-Jan-2024 | 13:30 | RNS |
Result of Retail Offer | 28-Dec-2023 | 07:00 | RNS |
Result of Placing and Subscription | 21-Dec-2023 | 18:25 | RNS |
Retail Offer | 21-Dec-2023 | 16:59 | RNS |
Placing and Subscription | 21-Dec-2023 | 16:55 | RNS |
CARDIO inCode-Score 510(k) FDA submission update | 29-Nov-2023 | 07:10 | RNS |
Change of Adviser | 29-Nov-2023 | 07:00 | RNS |
Half-year Report | 20-Sep-2023 | 07:00 | RNS |
Notice of Results | 13-Sep-2023 | 07:00 | RNS |
Currency | UK Pounds |
Share Price | 8.63p |
Change Today | -0.13p |
% Change | -1.43 % |
52 Week High | 16.50 |
52 Week Low | 3.45 |
Volume | 30,669 |
Shares Issued | 176.96m |
Market Cap | £15.26m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
16:26 | 11,699 @ 8.59p |
11:40 | 1,058 @ 8.85p |
11:19 | 4,016 @ 8.58p |
11:01 | 13,534 @ 8.80p |
08:48 | 200 @ 8.55p |
CEO | Matthew Heaton Walls |
CFO | Paul Andrew Peter Foulger |
COO | Jordi Puig Gilberte |
You are here: research